Expert Opinion on Orphan Drugs
Last updated ISSN 2167-8707
Expert Opinion on Orphan Drugs is published by Taylor & Francis in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Expert Opinion on Orphan Drugs is — and show you journals like it.
What it publishes
Recent work in Expert Opinion on Orphan Drugs concentrates on these topics, taken from its published record rather than from its own description:
- Lysosomal Storage Disorders Research
- Genomics and Rare Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Lymphoma Diagnosis and Treatment
- Diverse Scientific and Economic Studies
- Chronic Lymphocytic Leukemia Research
- Neurogenetic and Muscular Disorders Research
- Human auditory perception and evaluation
- Educational Robotics and Engineering
- Pharmaceutical Economics and Policy
Key facts
| Publisher | Taylor & Francis |
|---|---|
| ISSN | 2167-8707 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 862 |
| Publishing since | 2012 |
| Journal website | www.tandfonline.com/toc/ieod20/current |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Expert Opinion on Orphan Drugs
Other established journals in medicine, if this one is not the right home for your paper: